Skip to content
10-Q

Quarterly Report

Evolutionary Genomics, Inc.

0001553350-20-001004

← back to feed
Filed
Nov 13, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2020 · Sep 30, 2020 6.07M sh
Shares Diluted Q3 2020 · Sep 30, 2020 5.88M sh
Shares Diluted Q3 2020 · Sep 30, 2019 5.88M sh
Shares Diluted Q3 2020 · Sep 30, 2019 5.88M sh
Shares Outstanding Q3 2020 · Sep 30, 2020 5.88M sh
Short Term Investments Q3 2020 · Sep 30, 2020 $68.36K
Short Term Investments Q3 2020 · Dec 31, 2019 $41.69K
Current Liabilities Q3 2020 · Sep 30, 2020 $75.31K
Current Liabilities Q3 2020 · Dec 31, 2019 $19.42K
Total Liabilities Q3 2020 · Sep 30, 2020 $1.06M
Total Liabilities Q3 2020 · Dec 31, 2019 $1.01M
Current Assets Q3 2020 · Sep 30, 2020 $398.54K
Current Assets Q3 2020 · Dec 31, 2019 $118.16K
Total Assets Q3 2020 · Sep 30, 2020 $4.46M
Total Assets Q3 2020 · Dec 31, 2019 $4.24M
Net Income Q3 2020 · Jun 30, 2020 −$294.8K
Net Income Q3 2020 · Mar 31, 2020 −$241.82K
Net Income Q3 2020 · Sep 30, 2019 −$156.32K
Net Income Q3 2020 · Sep 30, 2019 −$538.46K
Net Income Q3 2020 · Jun 30, 2019 −$181.75K
Net Income Q3 2020 · Mar 31, 2019 −$200.4K
Operating Cash Flow Q3 2020 · Sep 30, 2019 −$453.26K
Cash And Equivalents Q3 2020 · Sep 30, 2019 $218.16K
Cash And Equivalents Q3 2020 · Dec 31, 2018 $131.41K
Stockholders Equity Q3 2020 · Sep 30, 2019 −$113.04K
Stockholders Equity Q3 2020 · Jun 30, 2019 $43.29K
Stockholders Equity Q3 2020 · Mar 31, 2019 $220.47K
Stockholders Equity Q3 2020 · Dec 31, 2018 $403.59K
Sga Expense Q3 2020 · Sep 30, 2019 $41.96K
Sga Expense Q3 2020 · Sep 30, 2019 $166.58K
Rd Expense Q3 2020 · Sep 30, 2019 $115.77K
Rd Expense Q3 2020 · Sep 30, 2019 $361.11K
Operating Income Q3 2020 · Sep 30, 2019 −$162.51K
Operating Income Q3 2020 · Sep 30, 2019 −$546.19K
Revenue Q3 2020 · Sep 30, 2019 $32.72K
Revenue Q3 2020 · Sep 30, 2019 $115.84K